- Home
- CATX vs FTF Comparison
CATX vs FTF Comparison
Compare CATX & FTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CATX | FTF |
|---|---|---|
| Founded | 1983 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.8M | 256.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CATX | FTF |
|---|---|---|
| Price | $2.40 | $6.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $11.56 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 153.9K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.45% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,075,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.60 | $5.76 |
| 52 Week High | $5.39 | $6.56 |
Technical Indicators
Market Signals| Indicator | CATX | FTF |
|---|---|---|
| Relative Strength Index (RSI) | 48.59 | 47.30 |
| Support Level | $2.07 | $6.02 |
| Resistance Level | $2.39 | $6.15 |
| Average True Range (ATR) | 0.19 | 0.05 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 74.36 | 73.68 |
Price Performance
Historical ComparisonAbout CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About FTF Franklin Limited Duration Income Trust of Beneficial Interest
Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.